Market Place
Sourcing Support
Annora Pharma`s Generics Lurasidone Hydrochloride Receives Approval in US
21 Aug 2024 //
FDA
NRx keeps antidepressant`s blockbuster hopes alive despite flop
30 Apr 2024 //
FIERCE BIOTECH
Macleods` Generic Lurasidone Hydrochloride Receives Approval in the U.S.
09 Jun 2023 //
FDA
Aurobindo`s Generic Lurasidone Hydrochloride Receives Approval in U.S.
10 Mar 2023 //
FDA
Alkem`s Generic Lurasidone Hydrochloride Receives Approval in the U.S.
13 Dec 2022 //
FDA
MSN`s Generic Lurasidone HCL Receives Approval in the U.S.
09 Sep 2022 //
FDA
Watson Labs Teva `s Generic Lurasidone Hydrochloride Receives Approval in US
08 Feb 2021 //
FDA
BeiGene, Sumitomo-Roivant, Roche-JHL and more
13 Sep 2019 //
FIERCE PHARMA
Roivant lines up $3B upfront in Sumitomo Dainippon deal
06 Sep 2019 //
FIERCEBIOTECH
Emcure Pharms Generic Lurasidone Hydrochloride Receives Approval in US
06 Sep 2019 //
FDA
Teva Pharms USA Generic Lurasidone Hydrochloride Receives Approval in US
20 May 2019 //
FDA
Piramal Health Care`s Lurasidone hydrochloride Receives Approval in US
26 Mar 2019 //
FDA
Sun Pharma Global`s Generic Lurasidone Hydrochloride Receives Approval in US
07 Jan 2019 //
FDA
Torrent Pharm`s Generic Lurasidone Hydrochloride Receives Approval in US
03 Jan 2019 //
FDA
Accord Healthcare`s Generic Lurasidone Hydrochloride Receives Approval in US
03 Jan 2019 //
FDA
Lupin`s Generic Lurasidone Hydrochloride Receives Approval in US
03 Jan 2019 //
FDA
Invagen Pharm`s Generic Lurasidone Hydrochloride Receives Approval in US
03 Jan 2019 //
FDA
Amneal Pharm`s Generic Lurasidone Hydrochloride Receives Approval in US
03 Jan 2019 //
FDA
NeuroRx Receives FDA Breakthrough Therapy Designation for NRX-101
13 Nov 2018 //
BUSINESSWIRE
Latuda (lurasidone hydrochloride) : Sumitomo D. Pharma vs. Alkem Laboratories
19 Oct 2018 //
PATENT LITIGATION
Latuda® (lurasidone HCl) : Sumitomo D. Pharma, Sunovion vs. Macleods Pharma
22 Sep 2018 //
PATENT LITIGATION
Latuda® (lurasidone HCl) : Sumitomo D. Pharma, Sunovion v. Macleods Pharma USA
13 Sep 2018 //
PATENT LITIGATION
Latuda (lurasidone HCl) : Sumitomo, Sunovion Pharma v. Piramal Healthcare UK
03 Sep 2018 //
PATENT LITIGATION
Latuda® (Lurasidone HCl) : Sumitomo Dainippon Pharma v. Par Pharmaceutical
08 Mar 2018 //
PATENT LITIGATION
Latuda® (Lurasidone HCl): Sumitomo Dainippon Pharma v. Invagen Pharmaceuticals
08 Mar 2018 //
PATENT LITIGATION
Latuda® (Lurasidone HCl): Sumitomo Dainippon Pharma v. Accord Healthcare
08 Mar 2018 //
PATENT LITIGATION
Latuda® (Lurasidone HCl) :Sumitomo Dainippon Pharma v. First Time US Generics
08 Mar 2018 //
PATENT LITIGATION
FDA Grants Sunovion’s Latuda Expanded Approval for Bipolar Depression
06 Mar 2018 //
BIOSPACE
Latuda® (Lurasidone Hcl): Sumitomo Dainippon Pharma v. Emcure Pharmaceuticals
13 Feb 2018 //
PATENT LITIGATION
Pharma companies fall foul of ABPI’s Code of Practice
14 Dec 2017 //
PHARMA TIMES
Sunovion’s Latuda® (lurasidone HCI) Receives Health Canada Approval
24 Jul 2017 //
BUSINESSWIRE
Zydus Pharm’s Generic Lurasidone HCL Receives Tentative Approval In US
07 Jul 2017 //
FDA
Par Pharm’s Generic Lurasidone Hcl Receives Tentative Approval In US
19 May 2017 //
FDA
Japanese Companies Make Cautious Return to Indian Pharma Market
04 Jan 2017 //
ECONOMIC TIMES
Watson`s Generic Lurasidone Hydrochloride Receives Approval In US
05 Dec 2016 //
FDA
Invagen`s Generic Lurasidone Hydrochloride Receives Tentative Approval In US
02 Dec 2016 //
FDA
Aurobindo`s Generic Lurasidone HCL Receives Tentative Approval In US
18 Nov 2016 //
FDA
Aurobindo`s Geneic Lurasidone HCL Receives Tentative Approval In US
18 Nov 2016 //
FDA
TV pharma ad spending, AbbVie`s Humira and Pfizer`s Lyrica continue to dominate
07 Nov 2016 //
FIERCE PHARMA
Accord Healthcare`s Generic Lurasidone Hcl Receives Tentative Approval In US
12 Oct 2016 //
FDA
Pharma TV ad spending rises in April, led by big brand names
04 May 2016 //
FIERCE PHARMA
Fake smiles star in Otsuka and Lundbeck`s DTC push for Rexulti in depression
10 Mar 2016 //
FIERCE PHARMA MARKETING
Sunovion announces positive results for antipsychotic drug
21 May 2015 //
BIOSPECTRUM ASIA
Takeda, Orexigen end CV study for obesity drug Contrave
13 May 2015 //
FIERCE PHARMA ASIA
Sumitomo Dainippon, Takeda call it quits on Japan Latuda agreement
07 May 2015 //
FIERCE PHARMA ASIA
Sumitomo Dainippon says Latuda for schizophrenia in Japan misses PhIII aims
27 Apr 2015 //
FIERCE PHARMA ASIA
It`s Like Viagra for Pharma Ads: Pfizer`s $1.4 Billion Marketing Blitz
30 Mar 2015 //
BLOOMBERG BUSINESS
